Standard of Care and Treatment Strategy

When you are first diagnosed with ITP, the natural goal seems to be getting your platelet count back into the “normal” range (usually 150,000 to 450,000). However, modern medical guidelines have shifted away from this. The goal of ITP treatment is hemostasis—ensuring your blood can clot well enough to prevent serious bleeding—not achieving a perfect number ^[1][2].

The Strategy: Hemostatic vs. Normal

In most adults, a platelet count of 20,000 to 30,000 is considered a commonly used minimum target for daily life ^[3][1]. While this is not a guarantee of safety—serious bleeding can occur above 30,000, and treatment must be individualized based on bleeding history, age, other illnesses, and anticoagulant use—targeting a “safe” count rather than a “normal” one minimizes the significant side effects that come with ITP medications ^[4][5].

If your counts are safely above your personal target and you have no bleeding, observation (watchful waiting) is often a reasonable choice for many adults, allowing you to avoid medication side effects entirely.

First-Line Treatments: The Initial Response

If your count drops to a dangerous level or you are actively bleeding, your doctor will likely initiate treatment.

• Corticosteroids (Prednisone or Dexamethasone): These drugs calm the immune system to stop platelet destruction.
  • The 6-Week Goal: International guidelines strongly recommend limiting steroid courses to roughly 6 weeks or less ^[6][7]. Long-term use is toxic to the body, causing risks like bone loss, weight gain, high blood pressure, mood/sleep changes, and high blood sugar ^[7]. Note: Steroids should not be stopped abruptly without medical instructions; they must be tapered down safely.
• IVIG (Intravenous Immunoglobulin): This is a “rescue” treatment made from donor plasma. It works very quickly (often within 24–48 hours) to raise platelets but the effect usually wears off within a few weeks ^[8][1]. It is typically reserved for situations where a rapid rise is needed, such as significant bleeding, before surgery, or pregnancy-specific situations ^[8].
• Emergency Rescue: Life-threatening bleeding is treated as a coordinated emergency. Your team may use IVIG, high-dose IV steroids, and platelet transfusions together to stabilize you immediately.

Second-Line Treatments: Managing Chronic ITP

If steroids don’t work or your counts drop as soon as they are tapered, you and your doctor will discuss “second-line” options. There is no “best” choice; the right one depends on your lifestyle and health history ^[6][9].

• TPO-Receptor Agonists (TPO-RAs): Drugs like eltrombopag, romiplostim, and avatrombopag tell your bone marrow to make more platelets ^[10][11]. They are very effective, but they carry a real risk of thrombosis (blood clots) and require regular monitoring of your counts and liver function ^[12][13].
• Rituximab: This is an IV infusion given in a short course (usually four weeks). It targets the B-cells that make the “bad” antibodies ^[6]. While many patients see an initial response, a durable long-term response is less common. It carries important risks including infection, infusion reactions, reduced vaccine responses, and requires Hepatitis B screening prior to use ^[14].
• Fostamatinib: An oral pill that blocks the specific signal used by the spleen to destroy platelets ^[15]. Key side effects include diarrhea, high blood pressure, liver-test abnormalities, and neutropenia (low white blood cells) requiring monitoring ^[16].

The Role of Splenectomy

Splenectomy (surgical removal of the spleen) was once a primary treatment for ITP. Because the spleen is the main site where platelets are destroyed, removing it can lead to a durable response or remission in roughly 60% to 70% of adults ^[17][18]. Relapse or the need for continued treatment is still possible.

Because the spleen also helps fight certain infections, surgery is now usually deferred for at least 12 months after diagnosis when feasible ^[17][19]. This delay allows time to see if the ITP resolves on its own or if it can be managed well with newer medications. If splenectomy is chosen, you must receive specific vaccinations (pneumococcal, meningococcal, and Hib) before surgery. You will also need a clear action plan for antibiotics and urgent care if you develop a fever post-surgery, as you carry a lifelong increased risk of certain infections and blood clots ^[12][19].

Balancing Risks

Every treatment for ITP is a balance. While low platelets carry a bleeding risk, treatments carry their own toxicities and clotting risks ^[12][20]. Decisions should be made through shared decision-making—a conversation where your values and lifestyle are just as important as the lab results ^[6][9].